文献速递重症综合管理与镇静镇痛心脑血管急症

ICU出院一年后COVID-19幸存者的客观与主观认知:人口学、临床与情绪因素的作用

Objective and subjective cognition in survivors of COVID-19 one year after ICU discharge: the role of demographic, clinical, and emotional factors.
PubMed 文献 · Crit Care · 2023-05-15
一句话结论两个医疗ICU的COVID-19幸存者出院12个月时30%存在客观认知损害,以额叶-皮质下功能障碍为主,主观认知抱怨不能识别客观损害。

本研究对两个医疗ICU的COVID-19危重症幸存者在出院1年后进行认知与情绪评估,用自评问卷(感知缺陷问卷、医院焦虑抑郁量表、戴维森创伤量表)筛查主观认知缺陷与情绪状态,并完成全面神经心理学评估,同时回顾性收集ICU入科时人口学与临床资料。最终分析80例,女性31.3%,61.3%接受机械通气,中位年龄60.73岁。30%存在客观认知损害,表现最差的是执行功能、加工速度与再认记忆;近1/3患者有认知抱怨,22.5%、26.3%、27.5%分别报告焦虑、抑郁、创伤后应激障碍(PTSD)症状。有无客观认知损害者的主观认知缺陷感知无显著差异;女性与PTSD症状与主观认知缺陷显著相关,认知储备与客观认知损害相关。

要点

  • 两个医疗ICU的COVID-19幸存者出院12个月时30%存在客观认知损害,表现最差为执行功能、加工速度与再认记忆。
  • 近1/3患者报告认知抱怨,但有无客观认知损害者的主观认知缺陷感知无显著差异。
  • 22.5%、26.3%、27.5%的患者分别报告焦虑、抑郁、PTSD症状。
  • 女性与PTSD症状是感知认知表现更差的预测因素;认知储备是客观认知功能的保护因素。

适用人群与场景

  • 两个医疗ICU的COVID-19危重症幸存者,出院1年后接受评估;最终分析80例,女性31.3%,61.3%接受机械通气,中位年龄60.73岁。

研究设计与关键结果

  • 研究类型为对两个医疗ICU的COVID-19幸存者出院1年后的认知与情绪评估研究;最终分析80例,女性31.3%,61.3%接受机械通气,中位年龄60.73岁。
  • 30%的COVID-19幸存者存在客观认知损害,表现最差的是执行功能、加工速度与再认记忆。
  • 近1/3患者报告认知抱怨;22.5%、26.3%、27.5%分别报告焦虑、抑郁、PTSD症状。
  • 有无客观认知损害的患者之间,主观认知缺陷感知无显著差异。
  • 女性与PTSD症状与主观认知缺陷显著相关;认知储备与客观认知损害相关。

证据类型、等级与局限

  • 证据类型:对两个医疗ICU的COVID-19幸存者出院1年后的认知与情绪评估研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,女性与PTSD症状是感知认知表现更差的预测因素,认知储备是客观认知功能的保护因素;主观认知抱怨不能替代客观神经心理学评估来识别客观认知损害。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Intensive Care Unit (ICU) COVID-19 survivors may present long-term cognitive and emotional difficulties after hospital discharge. This study aims to characterize the neuropsychological dysfunction of COVID-19 survivors 12 months after ICU discharge, and to study whether the use of a measure of perceived cognitive deficit allows the detection of objective cognitive impairment. We also explore the relationship between demographic, clinical and emotional factors, and both objective and subjective cognitive deficits.

METHODS: Critically ill COVID-19 survivors from two medical ICUs underwent cognitive and emotional assessment one year after discharge. The perception of cognitive deficit and emotional state was screened through self-rated questionnaires (Perceived Deficits Questionnaire, Hospital Anxiety and Depression Scale and Davidson Trauma Scale), and a comprehensive neuropsychological evaluation was carried out. Demographic and clinical data from ICU admission were collected retrospectively.

RESULTS: Out of eighty participants included in the final analysis, 31.3% were women, 61.3% received mechanical ventilation and the median age of patients was 60.73 years. Objective cognitive impairment was observed in 30% of COVID-19 survivors. The worst performance was detected in executive functions, processing speed and recognition memory. Almost one in three patients manifested cognitive complaints, and 22.5%, 26.3% and 27.5% reported anxiety, depression and post-traumatic stress disorder (PTSD) symptoms, respectively. No significant differences were found in the perception of cognitive deficit between patients with and without objective cognitive impairment. Gender and PTSD symptomatology were significantly associated with perceived cognitive deficit, and cognitive reserve with objective cognitive impairment.

CONCLUSIONS: One-third of COVID-19 survivors suffered objective cognitive impairment with a frontal-subcortical dysfunction 12 months after ICU discharge. Emotional disturbances and perceived cognitive deficits were common. Female gender and PTSD symptoms emerged as predictive factors for perceiving worse cognitive performance. Cognitive reserve emerged as a protective factor for objective cognitive functioning.

TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT04422444; June 9, 2021.

来源:Crit Care,查看原文。版权归原作者所有。

参考来源

  1. Godoy-González M, Navarra-Ventura G, Gomà G, et al. Objective and subjective cognition in survivors of COVID-19 one year after ICU discharge: the role of demographic, clinical, and emotional factors. Crit Care. 2023. PMID: 37189173. doi:10.1186/s13054-023-04478-7

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。